Active, Not Recruiting
Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR + / HER2- Breast Cancer
NCT06599216
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Harbin Medical Cancer Hospital Harbin, Heilongjiang, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China